Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023-2024: Erratum. - Hammitt LL; Espinoza JS; Keck JW; Hartman RM; Alvarez-Colon G; Burrage A; Campbell AP; Cardona F; Chappell J; Christensen L; Dawood FS; Desnoyers C; et al. (The Pediatric infectious disease journal, 2026)